Log in

Proteolysis of Pro-Gly-Pro-Leu in the Hippocampus, Cerebellum, and Cerebral Cortex in Rats after Intravenous Injection

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

We studied the dependence of the levels of Pro-Gly-Pro-Leu peptide and its metabolites (Gly-Pro-Leu, Pro-Gly-Pro, Gly-Pro and Pro-Gly) from the time of administration in the hippocampus, cerebellum, and cerebral cortex of rats. After intravenous injection of Pro-Gly-Pro-Leu, the maximum concentration of metabolites in the rat brain was found in 20-min sample (0.026% from the amount of introduced labeled tetrapeptide); it was by 2.6 times higher that after intranasal administration. The calculated ratios of the peptide content (AUC) in brain structures for Pro-Gly-Pro-Leu and its metabolites after intranasal and intravenous injection were in most cases >1; hence, the levels of these peptides in the cerebellum, hippocampus, and brain cortex after intravenous injection were slightly higher than after intranasal administration. From these data, content of Pro-Gly-Pro-Leu and its metabolites per 1 g of the cerebellum, hippocampus and cortex was calculated: the maximum concentrations of Pro-Gly-Pro-Leu in the cerebellum, hippocampus, and cortex were 15.63, 18.48, and 2.95 pmol/g, respectively.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Canada)

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. I. P. Ashmarin, A. A. Kamenskii, and L. A. Lyapina, Vopr. Biol. Med. Farm. Khimii, No. 1, 24-27 (2002).

  2. I. P. Ashmarin, E. P. Karazeeva, L. A. Lyapina, and G. E. Samonina, Biokhimia, 63, No. 2, 149-155 (1998).

    Google Scholar 

  3. I. P. Ashmarin, L. A. Lyapina, N. F. Myasoedov, et al., Patent RF No. 2252778, Use of the Tripeptide Pro-Gly-Pro as a Means of Preventing and Treatment of Diabetes, a Method of Preventing and Treatment of Diabetes and Pharmaceutical Composition for the of Preventing and Treatment of Diabetes, Byul. Izobr., No. 15 (May 27, 2005).

  4. A. M. Ul’yanov, L. A. Lyapina, and T. A. Shubina, Vopr. Biol., Med. Farm. Khimii, No. 4, 19-21 (2005).

  5. V. P. Shevchenko, I. Yu. Nagayev, K. V. Shevchenko, and N. F. Myasoedov, Radiokhimiya, 55, No. 3, 284-288 (2013).

    Google Scholar 

  6. K. V. Shevchenko, T. V. Vyunova, L. A. Andreeva, et al., Dokl. Akad. Nauk, 456, No. 5, 613-617 (2014).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K. V. Shevchenko.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 158, No. 7, pp. 43-48, July, 2014

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shevchenko, K.V., V’yunova, T.V., Andreeva, L.A. et al. Proteolysis of Pro-Gly-Pro-Leu in the Hippocampus, Cerebellum, and Cerebral Cortex in Rats after Intravenous Injection. Bull Exp Biol Med 158, 37–41 (2014). https://doi.org/10.1007/s10517-014-2686-7

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-014-2686-7

Key Words

Navigation